Literature DB >> 3357891

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

M T Quinn1, S Parthasarathy, D Steinberg.   

Abstract

Native low density lipoprotein (LDL) does not affect monocyte/macrophage motility. On the other hand, oxidatively modified LDL inhibits the motility of resident peritoneal macrophages yet acts as a chemotactic factor for circulating human monocytes. We now show that lysophosphatidylcholine (lyso-PtdCho), which is generated by a phospholipase A2 activity during LDL oxidation, is a potent chemotactic factor for monocytes. It is not chemotactic for neutrophils or for resident macrophages. Platelet-activating factor, after treatment with phospholipase A2, becomes chemotactic for monocytes, whereas the intact factor is not. Synthetic 1-palmitoyl-lyso-PtdCho showed chemotactic activity comparable to that of the lyso-PtdCho fraction derived from oxidized LDL. The results suggest that lyso-PtdCho in oxidized LDL may favor recruitment of monocytes into the arterial wall during the early stages of atherogenesis. Generation of lyso-PtdCho, either from LDL itself or from membrane phospholipids of damaged cells, could play a more general role in inflammatory processes throughout the body.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357891      PMCID: PMC280088          DOI: 10.1073/pnas.85.8.2805

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Hormone and neurotransmitter receptors in an established vascular endothelial cell line.

Authors:  V Buonassisi; J C Venter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

3.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

4.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages.

Authors:  T Schaffner; K Taylor; E J Bartucci; K Fischer-Dzoga; J H Beeson; S Glagov; R W Wissler
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

5.  Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents.

Authors:  E J Goetzl; C K Derian; A I Tauber; F H Valone
Journal:  Biochem Biophys Res Commun       Date:  1980-06-16       Impact factor: 3.575

6.  Cytolytic and membrane-perturbing properties of lysophosphatidylcholine.

Authors:  H U Weltzien
Journal:  Biochim Biophys Acta       Date:  1979-08-20

7.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

Authors:  K Kumagai; K Itoh; S Hinuma; M Tada
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

8.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

Authors:  J R Hessler; A L Robertson; G M Chisolm
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

9.  Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis.

Authors:  O W Portman; M Alexander
Journal:  J Lipid Res       Date:  1969-03       Impact factor: 5.922

10.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  120 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis.

Authors:  W H Cho; T Park; Y Y Park; J W Huh; C-M Lim; Y Koh; D-K Song; S-B Hong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

Review 3.  Spontaneous lipid transfer between organized lipid assemblies.

Authors:  R E Brown
Journal:  Biochim Biophys Acta       Date:  1992-12-11

Review 4.  Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation.

Authors:  S Chatterjee
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

5.  Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.

Authors:  S Parthasarathy; J Barnett
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway.

Authors:  Stefania Gardella; Cristina Andrei; Denise Ferrera; Lavinia V Lotti; Maria R Torrisi; Marco E Bianchi; Anna Rubartelli
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

7.  T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

Authors:  Caius G Radu; Li V Yang; Mireille Riedinger; Matthew Au; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

8.  Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.

Authors:  M Naito; K Yamada; T Hayashi; K Asai; N Yoshimine; A Iguchi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

9.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells.

Authors:  F Okajima; K Sato; H Tomura; A Kuwabara; H Nochi; K Tamoto; Y Kondo; Y Tokumitsu; M Ui
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.